Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Yotsuyanagi

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|March 29, 2002
[Progression of HBV and HCV hepatitis into the chronic stage and cancer]H Yotsuyanagi
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 1, 1995
[Hepatitis A virus marker]H Yotsuyanagi, K Koike, S Iino
Internal Medicine (Tokyo, Japan)|May 1, 1995
Takayasu's arteritis in prepulseless stage manifesting lymph node swelling and hepatosplenomegalyH Yotsuyanagi, N Chikatsu, Y Kaneko, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Cost Analysis for Management and Prevention of Hepatitis B Virus ReactivationM Akazawa, A Igarashi, H Yotsuyanagi, et al.
The Journal of Clinical Investigation|July 1, 1994
Induction of cell cycle progression by hepatitis B virus HBx gene expression in quiescent mouse fibroblastsK Koike, K Moriya, H Yotsuyanagi, et al.
Journal of Medical Virology|December 1, 1996
Chronic hepatitis A with persistent viral replicationK Inoue, M Yoshiba, H Yotsuyanagi, et al.
Journal of Medical Virology|May 1, 1993
Duration of viremia in human hepatitis A viral infection as determined by polymerase chain reactionH Yotsuyanagi, S Iino, K Koike, et al.
Gastroenterology|May 8, 2001
Hepatitis B virus genotypes and hepatocellular carcinoma in JapanH Fujie, K Moriya, Y Shintani, et al.
Cancer Letters|February 20, 1999
Compensatory apoptosis in preneoplastic liver of a transgenic mouse model for viral hepatocarcinogenesisK Koike, K Moriya, H Yotsuyanagi, et al.
Gastroenterologia Japonica|July 1, 1991
Interferon therapy for non-A, non-B chronic hepatitisS Iino, K Hino, T Kondo, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|March 29, 2002
[Progression of HBV and HCV hepatitis into the chronic stage and cancer]H Yotsuyanagi
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 1, 1995
[Hepatitis A virus marker]H Yotsuyanagi, K Koike, S Iino
Internal Medicine (Tokyo, Japan)|May 1, 1995
Takayasu's arteritis in prepulseless stage manifesting lymph node swelling and hepatosplenomegalyH Yotsuyanagi, N Chikatsu, Y Kaneko, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Cost Analysis for Management and Prevention of Hepatitis B Virus ReactivationM Akazawa, A Igarashi, H Yotsuyanagi, et al.
The Journal of Clinical Investigation|July 1, 1994
Induction of cell cycle progression by hepatitis B virus HBx gene expression in quiescent mouse fibroblastsK Koike, K Moriya, H Yotsuyanagi, et al.
Journal of Medical Virology|December 1, 1996
Chronic hepatitis A with persistent viral replicationK Inoue, M Yoshiba, H Yotsuyanagi, et al.
Journal of Medical Virology|May 1, 1993
Duration of viremia in human hepatitis A viral infection as determined by polymerase chain reactionH Yotsuyanagi, S Iino, K Koike, et al.
Gastroenterology|May 8, 2001
Hepatitis B virus genotypes and hepatocellular carcinoma in JapanH Fujie, K Moriya, Y Shintani, et al.
Cancer Letters|February 20, 1999
Compensatory apoptosis in preneoplastic liver of a transgenic mouse model for viral hepatocarcinogenesisK Koike, K Moriya, H Yotsuyanagi, et al.
Gastroenterologia Japonica|July 1, 1991
Interferon therapy for non-A, non-B chronic hepatitisS Iino, K Hino, T Kondo, et al.
Pageof 4